Cargando…
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
BACKGROUND: Ketamine is swiftly effective in a range of neurotic disorders that are resistant to conventional antidepressant and anxiolytic drugs. The neural basis for its therapeutic action is unknown. Here we report the effects of ketamine on the EEG of patients with treatment-resistant generalize...
Autores principales: | Shadli, Shabah Mohammad, Kawe, Tame, Martin, Daniel, McNaughton, Neil, Neehoff, Shona, Glue, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070106/ https://www.ncbi.nlm.nih.gov/pubmed/29718262 http://dx.doi.org/10.1093/ijnp/pyy032 |
Ejemplares similares
-
Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?
por: Shadli, Shabah M., et al.
Publicado: (2022) -
Higuchi’s fractal dimension, but not frontal or posterior alpha asymmetry, predicts PID-5 anxiousness more than depressivity
por: Kawe, Tame N. J., et al.
Publicado: (2019) -
Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker
por: Shadli, Shabah M., et al.
Publicado: (2021) -
Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020) -
An improved human anxiety process biomarker: characterization of frequency band, personality and pharmacology
por: Shadli, S M, et al.
Publicado: (2015)